Drug Policy – what is it in Poland and UE
Journal of Health Policy & Outcomes Research · 2012
DOI: 10.7365/jhpor.2012.1.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health Policy & Outcomes Research, 2012. Verfasst von Wojciech Giermaziak.
Abstract (Originalsprache)
Demographic situation – growth population of people advanced in years, greater detestability of illnesses connected with better diagnostic methods and partial covering of the costs of medicines from the public funds what causes the growth of financial expenditure for the protection of health. Considering the payment possibility of the public payer, which is obligated to finance health care services, decisions to be taken in this field must be based on clear specific requirements and defined and verified information. A proper state body which is authorized to create the structured and conscious drug policy should take planned operations aiming at rationalization of budgetary expenditure and furthermore the supply of safe, effective and cheap drugs to patients.
Zitieren
APA
Giermaziak, W. (2012). Drug Policy – what is it in Poland and UE. Journal of Health Policy & Outcomes Research. https://doi.org/10.7365/jhpor.2012.1.2
Vancouver
Giermaziak W. Drug Policy – what is it in Poland and UE. Journal of Health Policy & Outcomes Research. 2012. doi:10.7365/jhpor.2012.1.2
BibTeX
@article{Giermaziak2012,
author = {Giermaziak, Wojciech},
title = {Drug Policy – what is it in Poland and UE},
journal = {Journal of Health Policy & Outcomes Research},
year = {2012},
doi = {10.7365/jhpor.2012.1.2}
}
EUVIMED